Tags

Type your tag names separated by a space and hit enter

Features associated with the development of hallucinations in Parkinson's disease.
Acta Neurol Scand. 2006 Oct; 114(4):239-43.AN

Abstract

OBJECTIVE

To identify features related to the development of hallucinations in Parkinson's disease (PD).

MATERIALS AND METHODS

Seventy PD patients with hallucinations (group 1) and 60 PD patients without hallucinations (group 2) were evaluated for disease severity, presence of motor complications, rapid eye movement (REM) behavior disorder (RBD), and antiparkinsonian drug profile. The ages at the emergence of hallucinations and duration of disease in group 1 were matched with the ages at the last visit of those in group 2.

RESULTS

Disease severity and presence of motor complications were similar in both groups. RBD was more frequently encountered among hallucinators than among non-hallucinators (P = 0.007). The mean duration and daily doses of levodopa and other dopaminergic drugs did not differ in both groups; however, the usage of anticholinergics and amantadine were significantly more frequent in group 2, unexpectedly.

CONCLUSIONS

The presence of RBD was significantly more common in hallucinators; however, severity of PD, duration and daily doses of dopaminergic drugs were not associated with the emergence of hallucinations.

Authors+Show Affiliations

Department of Neurology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. drgulcinbenbir@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16942542

Citation

Benbir, G, et al. "Features Associated With the Development of Hallucinations in Parkinson's Disease." Acta Neurologica Scandinavica, vol. 114, no. 4, 2006, pp. 239-43.
Benbir G, Ozekmekçi S, Cinar M, et al. Features associated with the development of hallucinations in Parkinson's disease. Acta Neurol Scand. 2006;114(4):239-43.
Benbir, G., Ozekmekçi, S., Cinar, M., Beskardes, F., Apaydin, H., & Erginöz, E. (2006). Features associated with the development of hallucinations in Parkinson's disease. Acta Neurologica Scandinavica, 114(4), 239-43.
Benbir G, et al. Features Associated With the Development of Hallucinations in Parkinson's Disease. Acta Neurol Scand. 2006;114(4):239-43. PubMed PMID: 16942542.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Features associated with the development of hallucinations in Parkinson's disease. AU - Benbir,G, AU - Ozekmekçi,S, AU - Cinar,M, AU - Beskardes,F, AU - Apaydin,H, AU - Erginöz,E, PY - 2006/9/1/pubmed PY - 2006/12/9/medline PY - 2006/9/1/entrez SP - 239 EP - 43 JF - Acta neurologica Scandinavica JO - Acta Neurol Scand VL - 114 IS - 4 N2 - OBJECTIVE: To identify features related to the development of hallucinations in Parkinson's disease (PD). MATERIALS AND METHODS: Seventy PD patients with hallucinations (group 1) and 60 PD patients without hallucinations (group 2) were evaluated for disease severity, presence of motor complications, rapid eye movement (REM) behavior disorder (RBD), and antiparkinsonian drug profile. The ages at the emergence of hallucinations and duration of disease in group 1 were matched with the ages at the last visit of those in group 2. RESULTS: Disease severity and presence of motor complications were similar in both groups. RBD was more frequently encountered among hallucinators than among non-hallucinators (P = 0.007). The mean duration and daily doses of levodopa and other dopaminergic drugs did not differ in both groups; however, the usage of anticholinergics and amantadine were significantly more frequent in group 2, unexpectedly. CONCLUSIONS: The presence of RBD was significantly more common in hallucinators; however, severity of PD, duration and daily doses of dopaminergic drugs were not associated with the emergence of hallucinations. SN - 0001-6314 UR - https://www.unboundmedicine.com/medline/citation/16942542/Features_associated_with_the_development_of_hallucinations_in_Parkinson's_disease_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0001-6314&date=2006&volume=114&issue=4&spage=239 DB - PRIME DP - Unbound Medicine ER -